Titles
- A premium support system for Medicare: updated analysis of illustrative options1
- A public option for health insurance in the nongroup marketplaces: key design considerations and implications1
- A report from the Forum session: implementing the Medicare prescription drug benefit : continuing challenges for states1
- A resource guide for using Medicare’s enrollment race and ethnicity data1
- A risk-based approach to monitoring of clinical investigations questions and answers: guidance for industry1
- A single-payer health care system that is based on Medicare’s fee-for-service program: testimony before the Committee on the Budget, United States Senate1
- A state roadmap1
- A view of a bridge over the Ba-Fing or Black River1
- A view of public health and biomedical research1
- ACF cannot ensure that all child victims of abuse and neglect have court representation1
- ACF should improve oversight of head start to better protect children’s safety1
- ACOs' strategies for transitioning to value-based care: lessons from the Medicare shared savings program1
- ANDA submissions--amendments to abbreviated new drug applications under GDUFA1
- ANDA submissions: amendments and requests for final approval to tentatively approved ANDAs1
- ANDAs for certain highly purified synthetic peptide drug products that refer to listed drugs of rDNA origin1
- Abuse and neglect: CMS should strengthen reporting requirements to better protect individuals receiving hospice care : report to the Honorable Charles E. Grassley, United States Senate1
- Accelerating adoption of assistive technology to reduce physical strain among family caregivers of the chronically disabled elderly living at home1
- Acceptance and filing reviews for premarket approval applications (PMAs): guidance for industry and Food and Drug Administration staff1
- Access and use of electronic health information by individuals with cancer: 2017-20181
- Access to Medicare Part D plans: a comparison of metropolitan and nonmetropolitan areas1